Articles tagged with: Afuresertib
News»

This Monday was the third day of the 2013 American Society of Hematology (ASH) annual meeting, which was held in New Orleans.
More than any other day of the conference, Monday was packed with important myeloma presentations, from 7:00 in the morning until almost 8:00 in the evening.
This ASH update will summarize the oral presentation sessions about treatment-related myeloma studies that were held Monday morning. An ASH update that was published on Wednesday focused on the sessions that were held Monday afternoon and evening.
Monday morning started with three simultaneous …
News»

At this year’s American Society of Hematology (ASH) meeting, which will be held in early December, more than 100 oral presentations and about 400 poster presentations will summarize research focused on multiple myeloma.
Abstracts for these presentations are now available.
During the next several weeks, The Beacon will publish a series of articles previewing the myeloma-related studies from the ASH meeting that are of particular interest.
Each of the articles will cover abstracts related to a specific topic, such as new treatments under development, current treatments, stem cell transplantation, prognostic factors, and …
News»

Yesterday was the first day of the American Society of Hematology (ASH) 2011 annual meeting, which is being held in San Diego.
Although the day featured no oral presentations of new myeloma-related research, it started with an interesting educational session focused on multiple myeloma.
There also were a number of poster presentations during the day summarizing important new research findings.
The educational session in the morning featured three presentations by leading myeloma specialists.
Induction Therapy And Maintenance Treatment
The first presentation was by Dr. Donna Reece of the Princess Margaret Hospital in …